Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA allows Laureate RSG to submit eCTD
The 4 gigabyte test submission comprising chemistry, manufacturing and control (CMC), preclinical and clinical data was reviewed, validated and approved without errors and in record time. Regulatory Services
The 4 gigabyte test submission comprising chemistry, manufacturing and control (CMC), preclinical and clinical data was reviewed, validated and approved without errors and in record time. Regulatory Services
The dietary supplements include Omega-3, Probiotic, and Fruit & Veggie. Omega-3 provides two Omega-3s (according to Eicosapentaenoic Acid/EPA and Docosahexaenoic Acid/DHA standards) in an ultra-concentrated MiniGel. Omega-3, due
Under the terms of the agreement, LabCorp will continue to be the national laboratory for UnitedHealthcare and Oxford Health Plans. The company will be the laboratory provider for
Pantoprazole Sodium Delayed Release Tablets 20mg & 40mg are the generic version of Protonix of Wyeth. Pantoprazole Sodium tablets are indicated for the short-term treatment of erosive esophagitis
McBean served at Covidien’s Specialty Pharmaceuticals as vice president and general manager from March 2009 until May 2011 and was responsible for executing a successful turnaround of the
The company’s patented PLX cells release therapeutic proteins in response to a host of local and systemic inflammatory diseases. PLX cells are grown using the company’s proprietary 3D
The patent provides protection for co-delivery technology that is used in the company’s ImuXen product range. The patent covers a method which deals with packaging a protein vaccine
So far, Alliance has acquired the rights to more than 50 pharmaceutical products. The company distributes its products through wholesalers, retail pharmacies, hospitals and an international network of
The JV, registered in Kuwait as Avita Medical Mena (AVM), will be 70% controlled by Avita Medical. AVM will be responsible for sales and marketing efforts in the
Sirolimus is currently being evaluated in a Phase III study entitled ‘study assessing double-masked uveitis treatment’ (Sakura) to evaluate the safety and efficacy of different doses of sirolimus.